Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
C
|
Crown Holdings Inc
F:CWN
|
US |
|
B
|
Bowim SA
WSE:BOW
|
PL |
|
A
|
Airship AI Holdings Inc
NASDAQ:AISP
|
US |
|
Moskovskiy Kreditnyi Bank PAO
MOEX:CBOM
|
RU |
Wall St Price Targets
Price Targets Summary
Elicera Therapeutics AB
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 1.3652 EUR with a low forecast of 1.2632 EUR and a high forecast of 1.4975 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Elicera Therapeutics AB's stock price target?
Price Target
1.3652
EUR
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 1.3652 EUR with a low forecast of 1.2632 EUR and a high forecast of 1.4975 EUR.
What is the Revenue forecast for Elicera Therapeutics AB?
Projected CAGR
80%
Over the last 4 years, the compound annual growth rate for Revenue has been 1 060%. The projected CAGR for the next 3 years is 80%.
